» Articles » PMID: 11950826

Ablative Therapy for Liver Tumours

Overview
Journal Gut
Specialty Gastroenterology
Date 2002 Apr 16
PMID 11950826
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Established ablative therapies for the treatment of primary and secondary liver tumours, including percutaneous ethanol injection, cryotherapy, and radiofrequency ablation, are discussed. Newer techniques such as magnetic resonance imaging guided laser interstitial thermal therapy of liver tumours has produced a median survival rate of 40.8 months after treatment. The merits of this newly emerging technique are discussed, together with future developments, such as focused ultrasound therapy, which holds the promise of non-invasive thermoablation treatment on an outpatient basis.

Citing Articles

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma.

Renzulli M, Ramai D, Singh J, Sinha S, Brandi N, Ierardi A Cancers (Basel). 2021; 13(13).

PMID: 34283065 PMC: 8268054. DOI: 10.3390/cancers13133336.


Lesion outline and thermal field distribution of ablative in vitro experiments in myocardia: comparison of radiofrequency and laser ablation.

Li W, Liu J, Huang T, Zhong X, Yang D, Xie X BMC Cardiovasc Disord. 2020; 20(1):454.

PMID: 33081697 PMC: 7576753. DOI: 10.1186/s12872-020-01735-3.


Prediction of recurrent glioblastoma after laser interstitial thermal therapy: The role of diffusion imaging.

Mahammedi A, Bachir S, Escott E, Barnett G, Mohammadi A, Larvie M Neurooncol Adv. 2020; 1(1):vdz021.

PMID: 32642657 PMC: 7212867. DOI: 10.1093/noajnl/vdz021.


Interstitial brachytherapy for liver metastases and assessment of response by positron emission tomography: a case report.

Sharma D, Thulkar S, Kumar R, Rath G J Contemp Brachytherapy. 2016; 2(3):114-116.

PMID: 27853472 PMC: 5104830. DOI: 10.5114/jcb.2010.16922.


Effect of liver transplantation in combined hepatocellular and cholangiocellular carcinoma: a case series.

Wu D, Shen Z, Zhang Y, Wang J, Zheng H, Deng Y BMC Cancer. 2015; 15:232.

PMID: 25886479 PMC: 4409743. DOI: 10.1186/s12885-015-1252-7.


References
1.
Vogl T, Muller P, Mack M, Straub R, Engelmann K, Neuhaus P . Liver metastases: interventional therapeutic techniques and results, state of the art. Eur Radiol. 1999; 9(4):675-84. DOI: 10.1007/s003300050732. View

2.
Rhim H, Dodd 3rd G . Radiofrequency thermal ablation of liver tumors. J Clin Ultrasound. 1999; 27(5):221-9. DOI: 10.1002/(sici)1097-0096(199906)27:5<221::aid-jcu1>3.0.co;2-t. View

3.
Merkle E, Boll D, Boaz T, Duerk J, Chung Y, Jacobs G . MRI-guided radiofrequency thermal ablation of implanted VX2 liver tumors in a rabbit model: demonstration of feasibility at 0.2 T. Magn Reson Med. 1999; 42(1):141-9. DOI: 10.1002/(sici)1522-2594(199907)42:1<141::aid-mrm19>3.0.co;2-i. View

4.
Francica G, Marone G . Ultrasound-guided percutaneous treatment of hepatocellular carcinoma by radiofrequency hyperthermia with a 'cooled-tip needle'. A preliminary clinical experience. Eur J Ultrasound. 1999; 9(2):145-53. DOI: 10.1016/s0929-8266(99)00022-1. View

5.
De Jode M, Lamb G, Thomas H, Taylor-Robinson S, Gedroyc W . MRI guidance of infra-red laser liver tumour ablations, utilising an open MRI configuration system: technique and early progress. J Hepatol. 1999; 31(2):347-53. DOI: 10.1016/s0168-8278(99)80234-7. View